AXA S.A. - LION BIOTECHNOLOGIES INC ownership

Quarter-by-quarter ownership
AXA S.A. ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$5,192,000
+7.3%
696,882
+0.1%
0.02%0.0%
Q4 2016$4,841,000
-13.9%
696,518
+1.9%
0.02%
-8.0%
Q3 2016$5,625,000
-9.6%
683,505
-11.0%
0.02%
-10.7%
Q2 2016$6,219,000
+54.0%
767,761
-3.4%
0.03%
+55.6%
Q1 2016$4,039,000795,1320.02%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 3,187,607$24,608,0008.48%
ACUTA CAPITAL PARTNERS, LLC 1,915,000$14,784,0007.07%
P.A.W. CAPITAL CORP 200,000$1,544,0001.75%
Perceptive Advisors 3,000,161$23,161,0001.71%
NEXTHERA CAPITAL LP 152,266$1,175,0001.67%
Broadfin Capital, LLC 2,105,519$16,255,0001.00%
Trellus Management Company, LLC 60,539$467,0000.69%
Rhenman & Partners Asset Management AB 575,000$4,439,0000.67%
QVT Financial LP 1,433,700$11,068,0000.62%
Cormorant Asset Management, LP 499,815$3,859,0000.46%
View complete list of LION BIOTECHNOLOGIES INC shareholders